IAPP and early-onset autosomal dominant Alzheimer disease: Thus, by inhibiting amylin fibril aggregate formation under in vitro environment, chrysin demonstrated considerable anti-amylin potential, and this study gives a substantial lead that chrysin has the potential to be used as an anti-aggregation agent that could have disease-modifying effects in Alzheimer's disease.